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This article presents data related to the research article entitled “The
effect of coating type on mechanical properties and controlled drug
release of PCL/zein coated 45S5 bioactive glass scaffolds for bone
tissue engineering” [1]. We provide data on mechanical properties,
in vitro bioactivity and drug release of bioactive glass (BG) scaffolds
coated by poly (ε-caprolactone) (PCL) and zein used as a controlled
release device for tetracycline hydrochloride (TCH). By coating the
BG scaffolds with PCL or PCL/zein blend the mechanical properties
of the scaffolds were substantially improved, i.e., the compressive
strength increased from 0.00470.001 MPa (uncoated BG scaffolds)
to 0.1570.02 MPa (PCL/zein coated BG scaffolds). A dense bone-like
apatite layer formed on the surface of PCL/zein coated scaffolds
immersed for 14 days in simulated body ﬂuid (SBF). The data
describe control of drug release and in vitro degradation behavior of
coating by engineering the concentration of zein. Thus, the
developed scaffolds exhibit attractive properties for application in
bone tissue engineering research.ier Inc. This is an open access article under the CC BY license
/j.msec.2015.05.011
erials, Department of Materials Science and Engineering, University of
en, Germany.
Fereshteh), aldo.boccaccini@ww.uni-erlangen.de (A.R. Boccaccini).
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(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableSubject area Biology
More speciﬁc
subject areaDrug deliveryType of data Figure
How data was
acquiredFTIR spectrometer (Nicolet 6700), compressive strength (Zwick/RoellZ050 mechanical tester),
contact angle measuring instrument (DSA30 Kruess), pH meter (pH 7.4, Sigma-Aldrich, USA), UV–vis
spectrophotometer (Specord 40, Analytik Jena, Germany)Data format Analyzed
Experimental factors BG scaffolds were fabricated by the foam replication method
Experimental
featuresPCL and zein solutions in different concentrations were prepared by dissolving PCL in chloroform
and zein in ethanol. Then, scaffolds were coated by immersed in the solution.Data source location University of Erlangen-Nuremberg, Erlangen, Germany
Data accessibility Data is supplied with this article.Value of the data The data described here, PCL/zein composite as an organized innovative design coating, may be
helpful to researchers who are interested in applications in in-situ drug release in bone tissue
engineering. Composite PCL/zein coated BG scaffolds with a novel type of drug controlled-release are shown.
 Compressive strength and mechanical stability are shown to be signiﬁcantly increased via the
optimized method for dip coating the BG scaffolds by PCL and zein.1. Data, experimental design, materials and methods
The data provided here are stress–strain curves for uncoated and coated scaffolds with different
concentration of PCL and zein before and after immersion in SBF for 28 days (Fig. 1) and drug release
curves of BG scaffolds of uncoated and coated with PCL, PCL/zein and zein TCH-loaded (Fig. 2).
1.1. Fabrication of bioglass-based scaffolds
Fully reticulated polyurethane (PU) foams (45 ppi, Eurofoam, Germany) and 45S5 BG powder
(composition in wt%: 45% SiO2, 24.5% Na2O, 24.4% CaO and 6% P2O5) of particle size 5 mm have been
used to fabricate the scaffolds. The scaffolds were fabricated by the foam replication method,
following a similar process as described elsewhere [2].
1.2. Polymer coating procedure and drug loading
In order to obtain a dual PCL/zein coating, PCL/zein (Sigma-Aldrich, USA) (50:50% w/w) solution
was prepared by dissolving PCL in chloroform and zein in ethanol (Merck, Germany). Then, scaffolds
were coated by this solution for two times. For the drug loading together with the PCL/zein polymer,
TCH (0.5% w/v) was dissolved in ethanol solution and the coating procedure was performed similarly
as for the unloaded coatings [1].
Fig. 1. Effect of different concentration of (a) PCL, (b) PCL/zein composite coating with 3 wt% and (c) with 5 wt%, on the stress–
strain behavior of BG-based scaffolds in compression. (d) Stress–strain curve of PCL/zein coated of BG-based scaffolds with 5 wt
% of PCL/zein under compressive loads before and after immersion in SBF for 28 days.
Fig. 2. Released TCH from BG scaffolds of uncoated and coated with PCL, PCL/zein and zein TCH-loaded. The inserted curve
indicates more detail of the release curve in the ﬁrst 50 h.
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By coating the BG scaffolds with PCL or PCL/zein blend the mechanical properties of the scaffolds
were substantially improved, i.e. the compressive strength increased from 0.00470.001 MPa
(uncoated BG scaffolds) to 0.1570.02 MPa (PCL/zein coated BG scaffolds). The compressive strength
values of the coated scaffolds are close to the lower bound strength value for spongy bone. The
compressive strength of superﬁcial of osteochondral tissue is 0.079 MPa [3,4]. Fig. 1 shows typical
compressive stress–strain curves for uncoated and coated scaffolds with different concentration of
PCL and PCL/zein indicating the increase of both the compressive strength and the area under the
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increasing the concentration of polymer, the compressive strength of coated scaffolds was increased.
The SEM images of PCL, PCL/zein and zein-coated scaffolds showed a smooth surface of the struts and
no large microcracks present on scaffolds coated by PCL. Based on this data, the scaffold coated using a
solution of 2.5% PCL: 2.5% zein w/v (1:1) was chosen for further investigation. The porosity and the
compressive strength of the present coated scaffolds were  94% and 0.15 MPa, respectively.
1.4. Assessment of bioactivity of the PCL/zein coated scaffolds
Fig. 1d shows the mechanical behavior of the PCL/zein coated scaffolds before and after immersion
in SBF for 28 days. The compressive strength of the scaffolds decreased markedly during 28 days of
immersion in SBF (0.09470.004 MPa). The presence of bone-like apatite on the uncoated and coated
scaffolds was conﬁrmed by XRD, SEM and FTIR analyses. It is suggested that the PCL/zein coating will
positively affect the bioactive character of 45S5 BG scaffolds. Indeed a cell biology assessment of the
present scaffolds, in comparison to similar polymer coated BG scaffolds reported recently [5–7]
remains to be carried out. The weight loss data of scaffolds are also increased by increasing the
amount of zein. The weight loss for the PCL/zein (50:50) and zein ﬁlms were 16% and 39%,
respectively. It suggests that a majority of the zein component degraded after 28 days of immersion.
1.5. Drug release analysis
The absorbed drug within the coated scaffolds was released in a sustained manner over 10 days
(Fig. 2). Three trends were observed for the drug release proﬁles: rapid, very slow and controlled drug
released. The coated BG scaffolds containing zein have reduced release level compared to the
uncoated and the coated scaffolds without protein. This data suggest that the entrapment of the drug
by zein protein played an important role in the release behavior. The formation of protein–drug
interactions is likely to contribute to the kinetics of the process, which should be related to the
establishment of hydrogen bonds, van der Waals forces, and the release of solvent molecules [8,9]. The
prediction of the actual mechanism is challenging. Some of the reasons that make such prediction
difﬁcult are related to the fact that the interactions also depend on the degradation rate of both
components. In addition, there are difﬁculties for the evaluation of the enthalpy and entropic
contribution of the solvent [9]. ATR-FTIR spectra of the TCH-loaded scaffolds are shown in the
Supplementary data. To shed some light on the release rate of TCH from PCL/zein coated scaffolds a
logarithmic function is ﬁt to the experimental data. The function that we ﬁt is D¼17.9 ln(t)4.4785;
where D is the cumulative drug release percentage and “t” is the release time in hours. The analysis of
the data demonstrated that the total amount of TCH in PCL/zein coated scaffolds can be released after
less than 15 days, as observed in previous researches [5,7,10].Appendix A. Supporting information
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2015.07.013.References
[1] Z. Fereshteh, P. Nooeaid, M.H. Fathi, A. Bagri, A.R. Boccaccini, The effect of coating type on mechanical properties and
controlled drug release of PCL/zein coated 45S5 bioactive glass scaffolds for bone tissue engineering, Mater. Sci. Eng. C 54
(2015) 50–60.
[2] Q.Z. Chen, I.D. Thompson, A.R. Boccaccini, 45S5 Bioglasss-derived glass-ceramic scaffolds for bone tissue engineering,
Biomaterials 27 (2006) 2414–2425.
[3] P. Nooeaid, V. Salih, J.P. Beier, A.R. Boccaccini, Osteochondral tissue engineering : scaffolds, stem cells and applications
Scaffolds for osteochondral tissue engineering, J. Cell. Mol. Med. 16 (2012) 2247–2270.
Z. Fereshteh et al. / Data in Brief 4 (2015) 524–528528[4] O. Bretcanu, S. Misra, I. Roy, C. Renghini, F. Fiori, A.R. Boccaccini, V. Salih, In vitro biocompatibility of 45S5 Bioglasss-
derived glass–ceramic scaffolds coated with poly(3-hydroxybutyrate), J Tissue Eng. Regen. Med. 3 (2009) 139–148.
[5] Q. Yao, P. Nooeaid, J.A. Roether, Y. Dong, Q. Zhang, A.R. Boccaccini, Bioglasss-based scaffolds incorporating
polycaprolactone and chitosan coatings for controlled vancomycin delivery, Ceram. Int. 39 (2013) 7517–7522.
[6] N. Johari, M.H. Fathi, M.A. Golozar, Fabrication, characterization and evaluation of the mechanical properties of poly
(ε-caprolactone)/nano-ﬂuoridated hydroxyapatite scaffold for bone tissue engineering, Composites Part B 43 (2012)
1671–1675.
[7] P. Zhou, Y. Xia, J. Wang, C. Liang, L. Yu, W. Tang, S. Gu, S. Xu, Antibacterial properties and bioactivity of HACC- and HACC-
zein-modiﬁed mesoporous bioactive glass scaffolds, J. Mater. Chem. 1 (2013) 685–692B 1 (2013) 685–692.
[8] F.O.D e Sousa, J. Blanco-Méndez, A. Pérez-Estévez, R. Seoane-Prado, A. Luzardo-Álvarez, Effect of zein on biodegradable
inserts for the delivery of tetracycline within periodontal pockets, J. Biomater. Appl. 27 (2012) 187–200.
[9] A.K. Jaiswal, S.S. Kadam, V.P. Soni, J.R. Bellare, Improved functionalization of electrospun PLLA/gelatin scaffold by alternate
soaking method for bone tissue engineering, Appl. Surf. Sci. 268 (2013) 477–488.
[10] V. Mourino, A.R. Boccaccini, Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds,
J. R. Soc. Interface 7 (2010) 209–227.
